Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2010-018283-16 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| PRA Health Sciences | INDUSTRY |
| Syneos Health | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The SyNAPSe trial will study if giving intravenous (i.v.) progesterone within 8 hours of the injury for a total of 120 hours to severe traumatic brain injury patients improves their recovery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Progesterone | Active Comparator |
| |
| Lipid emulsion without progestrone | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Progesterone | Drug | Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glasgow Outcome Scale (GOS) | The GOS assesses mortality and disability in traumatic brain injury (TBI) patients according to the designation: Good Recovery, Moderate Disability, Severe Disability, Vegetative State or Dead. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Mortality at Month 1 | The mortality rate at one month will be compared between the two treatment groups. | 1 month post injury |
| Mortality at Month 6 | The mortality rate at six months will be compared between the two treatment groups. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Neta R. Nelson, MPH | BHR Pharma, LLC | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of South Alabama Medical Center | Mobile | Alabama | 36617 | United States | ||
| LAC+USC Medical Center |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17011666 | Background | Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2. doi: 10.1016/j.annemergmed.2006.07.932. Epub 2006 Sep 29. | |
| 18447940 |
| Label | URL |
|---|---|
| Trial website | View source |
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | BHR-100 | Progesterone: Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
| FG001 | Placebo | Lipid emulsion without progesterone: Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Nov 15, 2011 | May 20, 2022 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Lipid emulsion without progesterone | Drug | Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
|
| 6 months post injury |
| Glasgow Outcome Scale at 3 Months | The GOS assesses the mortality and disability in traumatic brain injury patients according to the designation: Good Recovery, Moderate Disability, Severe Disability, Vegetative State, or Dead. | Month 3 |
| Glasgow Outcome Scale - Extended (GOS-E) | The GOS-E assessment of mortality and disability in TBI patients extends the original five GOS categories of functional outcome to eight categories:
| 3 months and 6 months post injury |
| Short Form (36) Health Survey (SF-36) | The Short Form (36) Health Survey (SF-36) is a validated survey of patient health consisting of eight scaled scores which are the weighted sums of the questions in their section. The eight sections are: vitality, physical functioning, bodily pain, general health perceptions, role physical, role emotional, role mental and mental health. The maximum score is 30. A score of 23 or lower is indicative of cognitive impairment. The 8 scales can also be further summarized to provide a summary score for physical health and a summary score for mental health. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. | 3 months and 6 months post injury |
| Potentially Clinically Important On-Treatment Cerebral Perfusion Pressure (CPP) and Summary of Maximum Therapy Therapeutic Intensity Level (TIL) | Cerebral Perfusion Pressure (CPP) levels are presented according to clinically significant cut-off values. CPP was calculated from intracranial pressures and mean arterial pressures measured from Day through Day 6 after initiation of study medication, if an ICP monitor was in place. Specific therapies received during Days 1-6 are summarized according to the Therapeutic Intensity Level (TIL) by treatment group, as maximum level of therapy administered to the subject. | Admission through post-infusion Day 6 |
| Los Angeles |
| California |
| 90033 |
| United States |
| University of California San Diego Medical Center | San Diego | California | 92103 | United States |
| Denver Health Medical Center | Denver | Colorado | 80204 | United States |
| Christiana Care Health System Hospital | Newark | Delaware | 19718 | United States |
| Delray Medical Center | Delray Beach | Florida | 33431 | United States |
| Tallahassee Memorial Healthcare | Tallahassee | Florida | 32308 | United States |
| Tampa General Hospital | Tampa | Florida | 33606 | United States |
| Saint Alphonsus Regional Medical Center | Boise | Idaho | 83706 | United States |
| John H. Stroger Jr. Hospital of Cook County | Chicago | Illinois | 60612 | United States |
| Advocate Lutheran General Hospital | Park Ridge | Illinois | 60068 | United States |
| Saint John's Hospital | Springfield | Illinois | 62769 | United States |
| Wishard Health Services | Indianapolis | Indiana | 46202 | United States |
| Methodist Hospital | Indianapolis | Indiana | 46206 | United States |
| Mercy Medical Center | Des Moines | Iowa | 50314 | United States |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | United States |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | United States |
| University of Louisville Hospital | Louisville | Kentucky | 40202 | United States |
| LSU Health - Shreveport | Shreveport | Louisiana | 71103 | United States |
| Eastern Maine Medical Center | Bangor | Maine | 04401 | United States |
| Maine Medical Center | Portland | Maine | 04102 | United States |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | United States |
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | 01655 | United States |
| Bronson Methodist Hospital | Kalamazoo | Michigan | 49007 | United States |
| St. Mary's of Michigan | Saginaw | Michigan | 48604 | United States |
| University of Missouri Health Care | Columbia | Missouri | 65212 | United States |
| Truman Medical Center Hospital Hill | Kansas City | Missouri | 64108 | United States |
| Lester E. Cox Memorial Hospital | Springfield | Missouri | 65804 | United States |
| The Nebraska Medical Center | Omaha | Nebraska | 68198 | United States |
| Robert Wood Johnson University Hospital | New Brunswick | New Jersey | 08903 | United States |
| Albany Medical Center Hospital | Albany | New York | 12208 | United States |
| Westchester Medical Center | Valhalla | New York | 10595 | United States |
| Mission Hospital | Asheville | North Carolina | 28801 | United States |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | United States |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
| Wake Forest University-Baptist Medical Center | Winston-Salem | North Carolina | 27157 | United States |
| Summa Health System | Akron | Ohio | 44304 | United States |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | United States |
| Miami Valley Hospital | Dayton | Ohio | 45409 | United States |
| St. Elizabeth Health Center | Youngstown | Ohio | 44501 | United States |
| OU Medical Center | Oklahoma City | Oklahoma | 73104 | United States |
| Legacy Emanuel Hospital & Health Center | Portland | Oregon | 97227 | United States |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | United States |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | United States |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | United States |
| University of South Carolina School of Medicine | Columbia | South Carolina | 29203 | United States |
| Johnson City Medical Center | Johnson City | Tennessee | 37604 | United States |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | United States |
| Texas Tech University Health Sciences Center | El Paso | Texas | 79905 | United States |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | United States |
| Marshall University Joan C. Edwards School of Medicine | Huntington | West Virginia | 25701 | United States |
| West Virginia University Hospital | Morgantown | West Virginia | 26506 | United States |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | United States |
| Hospital Francisco Lopez Lima | General Roca | Río Negro Province | Argentina |
| Hospital de Emergencias Clemente Alvarez (HECA) | Rosario | Santa Fe Province | Argentina |
| Hospital Nacional "Profesor Alejandro Posadas" | Buenos Aires | Argentina |
| Hospital Regional De Comodoro Rivadavia (HRCR) | Comodoro Rivadavia | Argentina |
| Hospital Central de Mendoza | Mendoza | Argentina |
| Hospital San Martin | Paraná | Argentina |
| Hospital Dr. José Maria Cullen | Santa Fe | Argentina |
| Medizinische Universität Graz | Graz | Austria |
| Medizinische Universität Innsbruck | Innsbruck | Austria |
| Unfallkrankenhaus Salzburg | Salzburg | Austria |
| Landesklinikum Wiener Neustadt | Vienna | Austria |
| ULB Erasme | Brussels | Belgium |
| Ziekenhuis Oost-Limburg, Location Sint Jan | Genk | Belgium |
| Universitair Ziekenhuis Gent | Ghent | Belgium |
| University Hospital of the Free University Brussels (UZ Brussel) | Jette | Belgium |
| University Hospital Gasthuisberg | Leuven | Belgium |
| Chengdu Military General Hospital | Chengdu | China |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou | China |
| The 2nd Affiliated Hospital of Zhejiang University | Hangzhou | China |
| The Second Hospital of Shandong University | Jinan | China |
| Huashan Hospital of Fudan University | Shanghai | China |
| Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | China |
| General Hospital of Tianjin Medical University | Tianjin | China |
| The Affiliated Hospital of Xuzhou Medical College | Xuzhou | China |
| Fakultní nemocnice Brno Neurochirurgická klinika | Brno | Czechia |
| Fakultní nemocnice u sv. Anny v Brnĕ, Neurochirurgická klinika | Brno | Czechia |
| Fakultní Nemocnice Plzeň, Neurochirurgicé Oddĕlení | Pilsen | Czechia |
| Fakultní nemocnice Kralovske Vinohrady | Prague | Czechia |
| Tampere University Hospital | Tampere | Finland |
| Groupe Hospitalier Pellegrin | Bordeaux | France |
| Hôpital Pierre Wertheimer | Bron | France |
| Centre Hospitalier Universitaire de Grenoble- Hópital Michallon | La Tronche | France |
| CHRU de Lille- Hópital Roger Salengro | Lille | France |
| Centre Hospitalier Universitaire de Limoges | Limoges | France |
| Centre Hospitalier Universitaire Hôpital Nord | Marseille | France |
| Hópital Central - CHU de Nancy | Nancy | France |
| Groupe Hospitalier La Salpêtrière | Paris | France |
| Charité - Universitätsmedizin Berlin | Berlin | Germany |
| Krankenhaus Merheim | Cologne | Germany |
| Klinikum der J.W. Goethe-Universität | Frankfurt | Germany |
| Universitätsmedizin Göttingen | Göttingen | Germany |
| Berufsgenossenschaftliche Kliniken | Halle | Germany |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg | Germany |
| Universitätsklinikum Heidelberg | Heidelberg | Germany |
| Universitätsklinikum Gießen und Marburg gGmbH | Marburg | Germany |
| Klinikum Nürnberg | Nuremberg | Germany |
| Niels-Stensen-Kliniken | Osnabrück | Germany |
| Universitätsklinikum Ulm | Ulm | Germany |
| Honvédelmi Minisztérium Állami Egészségügyi Központ | Budapest | Hungary |
| Pécsi Tudományegyetem Általános Orvostudományi Kar | Pécs | Hungary |
| Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ | Szeged | Hungary |
| Rambam Medical Center | Haifa | Israel |
| Hadassah Medical Organization | Jerusalem | Israel |
| Rabin Medical Center | Petah Tikva | Israel |
| Tel Aviv Sourasky Medical Center | Tel Aviv | Israel |
| Chaim Sheba Medical Center | Tel Litwinsky | Israel |
| Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena | Milan | Italy |
| Fondazione San Raffaele del Monte Tabor | Milan | Italy |
| Azienda Ospedaliera San Gerardo | Monza | Italy |
| Azienda Ospedaliero Universitaria Maggiore della Caritá | Novara | Italy |
| Azienda Ospedaliera San Camillo Forlanini | Rome | Italy |
| Azienda Ospedaliero Universitaria Integrata di Verona | Verona | Italy |
| Hospital Raja Permaisuri Bainun | Ipoh | Malaysia |
| Hospital Kuala Lumpur | Kuala Lumpur | Malaysia |
| University Malaya Medical Centre | Kuala Lumpur | Malaysia |
| Hospital Tengku Ampuan Afzan | Kuantan | Malaysia |
| Sarawak General Hospital | Kuching | Malaysia |
| VU Medisch Centrum | Amsterdam | Netherlands |
| Universitair Medisch Centrum Groningen | Groningen | Netherlands |
| Spitalul Clinic Judetean de Urgenta Timisoara | Timișoara | Romania |
| State Budget Educational Institution of Higher Professional Education "Kemerovskaya State Medical Academy of Federal Agency of Healthcare and Social Development" | Kemerovo | Russia |
| State Professional Institution of High Professional Education "Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky of Ministry of Health and Social Development" | Krasnoyarsk | Russia |
| State Institution "Burdenko Neurosurgical Institute of RAMS" | Moscow | Russia |
| State Healthcare Facility "Murmansk Regional Clinical Hospital n.a. Bayandin" | Murmansk | Russia |
| Saint Petersburg Healthcare Institution "City Mariinsky Hospital" | Saint Petersburg | Russia |
| State Institution of Health Care "Sverdlovsk Regional Clinical Hospital #1" | Yekaterinburg | Russia |
| National Neuroscience Institute | Singapore | Singapore |
| National University Hospital | Singapore | Singapore |
| Singapore General Hospital | Singapore | Singapore |
| Hospital Universitario Germans Trias i Pujol | Badalona | Barcelona | Spain |
| Hospital Parc Taulí | Sabadell | Barcelona | Spain |
| Hospital General Universitario de Alicante | Alicante | Spain |
| Hospital Universitario de Bellvitge | Barcelona | Spain |
| Hospital Universitario Vall Hebrón | Barcelona | Spain |
| Hospital Universitario de Girona Dr. Josep Trueta | Girona | Spain |
| Hospital Universitario de Gran Canaria Dr. Negrín | Las Palmas de Gran Canaria | Spain |
| Hospital Universitario 12 de Octubre | Madrid | Spain |
| Hospital Universitari Son Espases | Palma de Mallorca | Spain |
| Hospital Universitario Virgen del Rocio | Seville | Spain |
| Hospital Clínico Universitario De Valencia | Valencia | Spain |
| Hospital Universitari i Politecnic La Fé de Valencia | Valencia | Spain |
| Taichung Veterans General Hospital | Taichung | Taiwan |
| National Taiwan University Hospital | Taipei | Taiwan |
| Chiang Mai University | Chiang Mai | Thailand |
| Faculty of Medicine, Prince of Songkla University | Hat Yai | Thailand |
| Khon Kaen Hospital | Khon Kaen | Thailand |
| Royal Preston Hospital | Fulwood | Preston | United Kingdom |
| Queen Elizabeth Hospital | Birmingham | United Kingdom |
| University Hospital Coventry | Coventry | United Kingdom |
| Leeds Teaching Hospitals NHS, Leeds General Infirmary | Leeds | United Kingdom |
| The Royal London Hospital | London | United Kingdom |
| The James Cook University Hospital | Middlesbrough | United Kingdom |
| Southampton University Hospital | Southampton | United Kingdom |
| Background |
| Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12(2):R61. doi: 10.1186/cc6887. Epub 2008 Apr 30. |
| 25493978 | Derived | Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10. |
| COMPLETED |
|
| NOT COMPLETED |
|
|
This number is the modified Intention-to-Treat (mITT) Population which includes all subjects who were randomized and in whom treatment with study drug was initiated.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | BHR-100 | Progesterone: Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
| BG001 | Placebo | Lipid emulsion without progesterone: Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean | Standard Deviation | years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
| ||||||||||||||||
| Race/Ethnicity, Customized | Count of Participants | Participants |
| ||||||||||||||||
| Region of Enrollment | Number | participants |
| ||||||||||||||||
| Glasgow Coma Score Motor Score | The Glasgow Coma Scale divides into three parameters: best eye response (E), best verbal response (V) and best motor response (M). The levels of response in the components of the Glasgow Coma Scale are 'scored' from 1, for no response, up to normal values of 4 (Eye-opening response) 5 ( Verbal response) and 6 (Motor response). | Count of Participants | Participants |
| |||||||||||||||
| Pupillary Response | Count of Participants | Participants |
| ||||||||||||||||
| Hypoxia | Count of Participants | Participants |
| ||||||||||||||||
| Hypotension | Count of Participants | Participants |
| ||||||||||||||||
| Marshall CT Classification | Marshall CT classification of TBI describes 6 categories of severity of TBI based on a non-contrast head CT with binary assessments for presence or absence of:
| Count of Participants | Participants |
| |||||||||||||||
| Traumatic Subarachnoid Hemorrhage | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Glasgow Outcome Scale (GOS) | The GOS assesses mortality and disability in traumatic brain injury (TBI) patients according to the designation: Good Recovery, Moderate Disability, Severe Disability, Vegetative State or Dead. | Only participants with data for this outcome are included. Missing values are first imputed by carrying forward the Month 3 GOS assessment. If a subject has neither the 3 nor the 6 month GOS, the missing value is imputed using the proportional odds model. | Posted | Count of Participants | Participants | 6 months |
|
|
| ||||||||||||||||||||||||||||||||||||
| Secondary | Mortality at Month 1 | The mortality rate at one month will be compared between the two treatment groups. | P-value population size is based on the number of subjects with status = alive or dead, month 6 within the mITT population. | Posted | Count of Participants | Participants | 1 month post injury |
|
| |||||||||||||||||||||||||||||||||||||
| Secondary | Mortality at Month 6 | The mortality rate at six months will be compared between the two treatment groups. | P-value population size is based on the number of subjects with status = alive or dead, month 6 within the mITT population. | Posted | Count of Participants | Participants | 6 months post injury |
|
| |||||||||||||||||||||||||||||||||||||
| Secondary | Glasgow Outcome Scale at 3 Months | The GOS assesses the mortality and disability in traumatic brain injury patients according to the designation: Good Recovery, Moderate Disability, Severe Disability, Vegetative State, or Dead. | Posted | Count of Participants | Participants | Month 3 |
|
| ||||||||||||||||||||||||||||||||||||||
| Secondary | Glasgow Outcome Scale - Extended (GOS-E) | The GOS-E assessment of mortality and disability in TBI patients extends the original five GOS categories of functional outcome to eight categories:
| Number analyzed (591 for BHR-100 and 588 for placebo) is as listed in the clinical study report. The number analyzed was not modified per time frame and outcome, rather 591 and 588 are included. | Posted | Count of Participants | Participants | 3 months and 6 months post injury |
|
| |||||||||||||||||||||||||||||||||||||
| Secondary | Short Form (36) Health Survey (SF-36) | The Short Form (36) Health Survey (SF-36) is a validated survey of patient health consisting of eight scaled scores which are the weighted sums of the questions in their section. The eight sections are: vitality, physical functioning, bodily pain, general health perceptions, role physical, role emotional, role mental and mental health. The maximum score is 30. A score of 23 or lower is indicative of cognitive impairment. The 8 scales can also be further summarized to provide a summary score for physical health and a summary score for mental health. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. | Only participants with data for these parameters have been included. | Posted | Mean | Standard Deviation | score on a scale | 3 months and 6 months post injury |
| |||||||||||||||||||||||||||||||||||||
| Secondary | Potentially Clinically Important On-Treatment Cerebral Perfusion Pressure (CPP) and Summary of Maximum Therapy Therapeutic Intensity Level (TIL) | Cerebral Perfusion Pressure (CPP) levels are presented according to clinically significant cut-off values. CPP was calculated from intracranial pressures and mean arterial pressures measured from Day through Day 6 after initiation of study medication, if an ICP monitor was in place. Specific therapies received during Days 1-6 are summarized according to the Therapeutic Intensity Level (TIL) by treatment group, as maximum level of therapy administered to the subject. | Only participants with data for these parameters have been included. | Posted | Count of Participants | Participants | Admission through post-infusion Day 6 |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | BHR-100 | Progesterone: Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. | 109 | 596 | 224 | 596 | 265 | 596 |
| EG001 | Placebo | Lipid emulsion without progesterone: Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs. | 95 | 583 | 214 | 583 | 286 | 583 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Intracranial pressure increased | Nervous system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Brain oedema | Nervous system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hydrocephalus | Nervous system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Convulsion | Nervous system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Cerebral infarction | Nervous system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Pneumonia | Infections and infestations | MedDRA (13.0) | Systematic Assessment |
| |
| Sepsis | Infections and infestations | MedDRA (13.0) | Systematic Assessment |
| |
| Septic shock | Infections and infestations | MedDRA (13.0) | Systematic Assessment |
| |
| Meningitis | Infections and infestations | MedDRA (13.0) | Systematic Assessment |
| |
| Brain herniation | Injury, poisoning and procedural complications | MedDRA (13.0) | Systematic Assessment |
| |
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA (13.0) | Systematic Assessment |
| |
| Brain contusion | Injury, poisoning and procedural complications | MedDRA (13.0) | Systematic Assessment |
| |
| Traumatic brain injury | Injury, poisoning and procedural complications | MedDRA (13.0) | Systematic Assessment |
| |
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Cardiac arrest | Cardiac disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Cardio-respiratory arrest | Cardiac disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Multi-organ failure | Cardiac disorders | MedDRA (13.0) | Systematic Assessment |
|
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Pyrexia | General disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypophosphataemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypernatraemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypocalcaemia | Metabolism and nutrition disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypertension | Vascular disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Hypotension | Vascular disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Anaemia | Blood and lymphatic system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Constipation | Gastrointestinal disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Gamma-glutamyltransferase increased | Investigations | MedDRA (13.0) | Systematic Assessment |
| |
| Alanine aminotransferase increased | Investigations | MedDRA (13.0) | Systematic Assessment |
| |
| Tachycardia | Cardiac disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Agitation | Psychiatric disorders | MedDRA (13.0) | Systematic Assessment |
| |
| Diabetes insipidus | Endocrine disorders | MedDRA (13.0) | Systematic Assessment |
|
Treatment Emergent Adverse Events with Incidence of >5% by System Organ Class and Preferred Term (Safety Population) data was reported in the Other (Not Including Serious) Adverse Events section. Adverse events were reported for the modified Intention-to-Treat (mITT) population which includes all subjects who were randomized and in whom treatment with study drug was initiated (analyzed according to randomized treatment).
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Global Chief Medical Officer | Besins Healthcare Ireland Ltd | +353 87 1039215 | clinicaldevelopment@besins-healthcare.com |
| Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Apr 19, 2014 | May 20, 2022 | SAP_001.pdf |
| ID | Term |
|---|---|
| D001930 | Brain Injuries |
| D014947 | Wounds and Injuries |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
Not provided
Not provided
| ID | Term |
|---|---|
| D011374 | Progesterone |
| ID | Term |
|---|---|
| D011282 | Pregnenediones |
| D011283 | Pregnenes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D003339 | Corpus Luteum Hormones |
| D042341 | Gonadal Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D045167 | Progesterone Congeners |
| D012739 | Gonadal Steroid Hormones |
Not provided
Not provided
| Male |
|
| Not Hispanic or Latino |
|
| Unknown or Not Reported |
|
| Black/African American/African Heritage |
|
| Native Hawaiian/other Pacific Islander |
|
| Asian |
|
| American Indian or Alaska Native |
|
| Not Allowed to Obtain |
|
| Other |
|
| Romania |
|
| Singapore |
|
| Hungary |
|
| United States |
|
| Czechia |
|
| United Kingdom |
|
| Malaysia |
|
| Thailand |
|
| Russia |
|
| Spain |
|
| Austria |
|
| Netherlands |
|
| Belgium |
|
| China |
|
| Finland |
|
| Taiwan |
|
| Italy |
|
| Israel |
|
| France |
|
| Germany |
|
| 3 |
|
| 4 |
|
| 5-6 |
|
| Missing |
|
| Unilateral |
|
| No Reactive Pupils |
|
| Not Testable |
|
| Missing |
|
| No |
|
| Suspected |
|
| Unknown |
|
| No |
|
| Suspected |
|
| Unknown |
|
| II |
|
| III |
|
| IV |
|
| Evacuated/Non-Evacuated Mass Lesion |
|
| Missing |
|
| No |
|
| Missing |
|
| Severe Disability |
|
| Vegetative State/Dead |
|
|
|
|
|
|
|
| Participants |
|
|